Skip links

Esbriet® (pirfenidone)

Full Name Esbriet® (pirfenidone)
Drug Esbriet
Manufacturer Genentech
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of idiopathic pulmonary fibrosis (IPF)
Disease Idiopathic Pulmonary Fibrosis (IPF)
Therapeutic Area Pulmonology
Enrollment Form Link Enrollment Form
Phone Number 800-355-9366
Fax Number 877-358-9246
Product Website esbriethcp.com